Partner Sites
Executive War College
The Dark Report
Dark Daily
G2 Intelligence
Trends
Events
Digital Forums
Webinars
Resources
Ebooks
Infographics
White Papers
Magazine
Login
Subscribe Today
Business & Policy
Advocacy & Professional Affairs
FDA, CMS & Regulatory Frameworks
IVD Market
M&A, Consolidation & Competitive Landscape
Market Trends & Business Intelligence
Payer Policy
Public Health & Population Testing Strategy
Lab Operations
Budgeting, Cost Control & Purchasing Strategy
Procurement & Vendor Alignment
Remote/Hub-and-Spoke Testing Networks
Revenue Cycle Management
Sustainability & Resource Efficiency
Workflow Optimization & Lean Lab Design
Workforce, Staffing & Training
Compliance
Biosafety, Biosecurity & Risk Management
CLIA, Regulatory, & Accreditation
Data Integrity & Traceability
Proficiency Testing & External QC
Quality Control & Quality Assurance
Validation, Verification & Method Comparison
Emerging Tech
Cell & Gene Therapy Diagnostic Interfaces
Digital Pathology, AI & Computational Diagnostics
Genomics, Proteomics, & Metabolomics
Liquid Biopsy & Early Detection
Precision Medicine & Companion Diagnostics
Tools & Techniques
Analyzers, Automation, & Diagnostic Platforms
Consumables & Lab Supplies
LIMS, Data Systems & Digital Workflows
Liquid Handling & Laboratory Robotics
Microscopy & Digital Pathology Imaging
PCR & qPCR Systems
Sample Prep & Processing Systems
Sequencing & Multiomics Platforms
Diagnostics & Testing
Clinical Chemistry
Hematology, Hemostasis, & Urinalysis
Microbiology & Infectious Disease
Molecular Diagnostics
Pathology & Histology
Point-of-Care Testing
Specimen Collection, Transport, & Pre-Analytical Processes
Toxicology & Pharmacology
Subscribe
Subscribe Today
Daniel Millard, PhD
Daniel Millard, PhD is the applications director at Axion Biosystems. He and his team develop and implement advanced applications for the Maestro multiwell microelectrode array platform, a first-in-class high-throughput electrophysiology device.
Articles by Daniel Millard, PhD
Thought Leadership
|
5+ min read
5 Assays for Testing Adoptive Cell Therapy Quality
The benefits and limitations of five popular cell viability assays
by
Daniel Millard, PhD
Page 1 of 1
1
Sponsored
Bridging Vision and Execution: A Candid Conversation on the Future of the Laboratory
Sponsored by
Your Model From Our Experience: Cloud First Digital Pathology in a High-Volume Regional Laboratory
Sponsored by
Ensuring Compliance: How to Get AI Diagnostic Tools Approved for Clinical Practice
Sponsored by
Cutting-Edge Gastrointestinal Pathogen Testing Technologies for Labs
Sponsored by
